Microplastic Claims: Litigation Under the Clean Water Act and RCRA, Claims Brought in Derivative Lawsuits
Recording of a 90-minute CLE video webinar with Q&A
This CLE webinar will examine microplastics litigation. The panel will discuss recent cases that have been brought under the Clean Water Act (CWA) and Resource Conservation and Recovery Act (RCRA) and the unique circumstances when claims have been brought by shareholders in derivative lawsuits against manufacturers. The panel will discuss the current state of litigation and how manufacturers may mitigate risks, as well as what options a plaintiff may have when pursuing a claim.
- Microplastic litigation
- Clean Water Act
- Recent cases
- Resource Conservation and Recovery Act
- Recent cases
- Derivative shareholder suits
- Other microplastic litigation
- Manufacturer's risk mitigation
The panel will address these and other key issues:
- How are claims under the CWA for microplastics most likely pursued?
- What must a manufacturer show to avoid liability under RCRA?
- What should boards and management consider when making environmental sustainability claims to avoid derivative suits?
Megan E. Baroni
Robinson & Cole
Ms. Baroni has extensive experience counseling clients on a wide variety of environmental, health, and safety issues.... | Read More
Ms. Baroni has extensive experience counseling clients on a wide variety of environmental, health, and safety issues. She frequently represents manufacturers and distributors and is a contributing author to the firm's Manufacturing Law Blog, focusing on environmental, health, and safety trends that will impact the industry. Ms. Baroni is a trusted advisor on complex environmental compliance issues, including the investigation, remediation, and redevelopment of contaminated properties; chemical and waste management associated with business operations; management of contaminated building materials; and risk management in crisis situations. When disputes arise, she is a zealous advocate, working hand-in-hand with our clients to effectively manage and ultimately resolve them. Her deep understanding of the science at work in environmental cases helps make her truly knowledgeable about the issues at hand. She commonly works with experts in the field to develop a comprehensive strategy to support our clients’ goals and objectives.Close
Catherine Boston, MPH, DABT
Principal Scientist, Risk Assessor
Ms. Boston combines her background in geology with her human health risk assessment and statistical expertise to... | Read More
Ms. Boston combines her background in geology with her human health risk assessment and statistical expertise to provide multi-disciplinary support for remedial investigations and in environmental litigation. Her areas of expertise in toxicology and human health risk include emerging contaminants, quantitative risk assessment, exposure assessments, and general causation assessments. Ms. Boston conducts quantitative human health risk assessments and negotiates with regulatory agencies in support of remedial investigations and remediation at contaminated properties across the U.S. for industry, developers, and municipalities. In an environmental litigation context, Ms. Boston has experience advising clients regarding potential adverse health outcomes associated with alleged exposure to a wide variety of products and chemicals (including, but not limited to talc, heavy metals, pesticides/herbicides, and various volatile organic compounds).Close